John Orwin

Non Executive / Other Non-Executive
Login/ Register  to follow report
Company:

About

Mr. Orwin joined the Seagen Board of Directors in January 2014. With many years of experience as a senior executive at leading pharmaceutical and biotechnology companies, he brings a strong understanding of the industry and the challenges we must meet to continue developing and commercializing product candidates.

Mr. Orwin is the President and Chief Executive Officer of Atreca, Inc. Previously, he was the Chief Executive Officer of Relypsa, Inc., now an affiliate of Vifor Pharma AG. Mr. Orwin also held multiple leadership roles at Affymax, Inc., including Chief Executive Officer, President, and Chief Operating Officer. Earlier in his career, he led the BioOncology Business Unit at Genentech, Inc. and was the Franchise Vice President of Tibotec Therapeutics at Johnson & Johnson.

Mr. Orwin holds an M.B.A. from the Stern School of Business at New York University and a B.A. in Economics from Rutgers University. He serves as Chairman of the Board for AnaptysBio, Inc. and as a member of the board of directors for Atreca, Inc. and Travere Therapeutics, Inc.

 

Personal Details

Title: Mr
Surname: Orwin
DoB: 01/01/1972
Age: 54 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: B.A Economics, M.B.A
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

 

Working history

Name

Member

Johnson and Johnson
Appointed Date: 01/07/2001
Date Resigned: 01/12/2004
Industry: Healthcare

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
Seattle GeneticsOther (specify)Member01/01/2014
Seattle GeneticsBoardMember01/01/2014

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF